Member access

4-Traders Homepage  >  Shares  >  Euronext Bruxelles  >  UCB    UCB   BE0003739530

UCB (UCB)

320
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Bruxelles
03/23/2015 03/24/2015 03/25/2015 03/26/2015 03/27/2015 Date
69.07(c) 69.37(c) 68.25(c) 67.62(c) 68.49(c) Last
236 409 186 321 292 030 369 486 243 579 Volume
-0.25% +0.43% -1.61% -0.92% +1.29% Change
More quotes
Financials (€)
Sales 2015 3 621 M
EBIT 2015 539 M
Net income 2015 311 M
Debt 2015 1 407 M
Yield 2015 1,71%
Sales 2016 3 928 M
EBIT 2016 694 M
Net income 2016 424 M
Debt 2016 1 215 M
Yield 2016 1,86%
PER 2015 41,63
PER 2016 29,58
EV / Sales 2015 4,07x
EV / Sales 2016 3,70x
Capitalization 13 322 M
More Financials
Company
UCB SA is a biopharmaceutical company that engages in the research, development and commercialization of innovative drugs in the fields of central nervous system and immunology disorders.It focuses on the discovery and development of innovative medicines and solutions to transform the lives of... 
Sector
Pharmaceuticals
Calendar
04/30Earnings Release
More about the company
Surperformance© ratings of UCB
Trading Rating : Investor Rating :
More Ratings
Latest news on UCB
03/27 UCB : Convening notice to attend the general meeting of shareholders
03/25 UCB : Findings from UCB Pharma SA Yields New Findings on Toxicology (Identificat..
02/12 UCB : Patent Issued for Systems for Administering Medication
02/12 UCB : Patent Issued for Syringe Safety Assembly
01/28 UCB : announces US and EU regulatory filings for the investigational antiepilept..
01/12 UCB : Update of transparency notification UCB SA/NV
01/09 DERMIRA : and UCB announce start of Phase 3 program for CIMZIA (certolizumab peg..
01/07 UCB : Acquisition of own shares
More news
Sector news : Biopharmaceuticals
03/28 GLAXOSMITHKLINE : GSK statement on meningitis vaccination in the UK
03/27 HOSPIRA : first biosimilar could be its first to gain FDA approval
03/27 VALEANT PHARMACEUTICALS INTL : S&P Dow Jones Indices Announces Changes to the S&..
More sector news : Biopharmaceuticals
News from SeekingAlpha
02/08 WEEK IN REVIEW : WuXi NextCode Leads $15 Million Financing In Claritas Genomics


Comments 
Advertisement
Chart UCB
Duration : Period :
UCB Technical Analysis Chart | UCB | BE0003739530 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF